BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11231731)

  • 21. Drugs, debates, deals, and deficits.
    Scott JS
    Healthc Financ Manage; 2002 Dec; 56(12):30, 33. PubMed ID: 12516156
    [No Abstract]   [Full Text] [Related]  

  • 22. Prescription drug access: the ANA adopts principles to evaluate congressional Medicare proposals.
    McKeon E
    Am J Nurs; 2003 Sep; 103(9):106. PubMed ID: 14501485
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacy compliance with a prescription-drug discount program.
    Knapp KK; Law AV; Hitchman C
    N Engl J Med; 2002 Jul; 347(2):146-7; author reply 146-7. PubMed ID: 12110750
    [No Abstract]   [Full Text] [Related]  

  • 24. Perspectives. What the drug benefit looks like now.
    Med Health; 2003 Nov; 57(43):1, 7-8. PubMed ID: 14723115
    [No Abstract]   [Full Text] [Related]  

  • 25. Medicare Part D--the product of a broken process.
    Slaughter LM
    N Engl J Med; 2006 Jun; 354(22):2314-5. PubMed ID: 16738267
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug card setback highlights need for cost relief.
    Gundling RL
    Healthc Financ Manage; 2003 Apr; 57(4):50-4. PubMed ID: 12735187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some over-the-counter advice on making drug therapy work. Interview by Patrick Mullen.
    Gans JA
    Manag Care; 2001 Oct; 10(10):41-2, 44, 47. PubMed ID: 11764745
    [No Abstract]   [Full Text] [Related]  

  • 28. Catastrophic health insurance: budget and policy issues.
    Helms RB
    Am J Pharm Educ; 1989; 53(4):356-9. PubMed ID: 10304253
    [No Abstract]   [Full Text] [Related]  

  • 29. Medicare agreement: premium support demo ... maybe.
    Med Health; 2003 Nov; 57(43):1-2. PubMed ID: 14723114
    [No Abstract]   [Full Text] [Related]  

  • 30. Congress shapes a prescription drug benefit.
    Baxter MD
    Oncologist; 2003; 8(4):392-4. PubMed ID: 12897337
    [No Abstract]   [Full Text] [Related]  

  • 31. Medicare drug therapy in the elderly: pharmacotherapy, politics, and economics at the crossroads.
    Wenger NK; Weber MA; Scheidt S
    Am J Geriatr Cardiol; 2005; 14(6):282-3. PubMed ID: 16276123
    [No Abstract]   [Full Text] [Related]  

  • 32. Medicare Part D: an overview of its practical and clinical impact.
    Usdin S
    Am J Geriatr Cardiol; 2005; 14(6):284-8; quiz 289-90. PubMed ID: 16276124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An introduction to the Medicare Prescription Drug, Improvement, and Modernization Act of 2003.
    Siegel S
    Health Care Law Mon; 2004 Jan; ():3-14. PubMed ID: 14750394
    [No Abstract]   [Full Text] [Related]  

  • 34. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. More than the drug benefit.
    Olsen GG
    Rehab Manag; 2004 Apr; 17(3):42-4. PubMed ID: 15067925
    [No Abstract]   [Full Text] [Related]  

  • 36. Part I--Medicare prescription drug coverage (Part D): the promise.
    Witten B
    Nephrol News Issues; 2006 Jul; 20(8):14, 17-8. PubMed ID: 16859229
    [No Abstract]   [Full Text] [Related]  

  • 37. Can we afford all this?
    Dickerson JF
    Time; 2003 Dec; 162(23):48-51. PubMed ID: 14712554
    [No Abstract]   [Full Text] [Related]  

  • 38. Affordable prescription drugs for NC consumers: the next challenge.
    Savage HH
    N C Med J; 2003; 64(6):298-9. PubMed ID: 14983624
    [No Abstract]   [Full Text] [Related]  

  • 39. The prescription-drug problem.
    Steinbrook R
    N Engl J Med; 2002 Mar; 346(11):790. PubMed ID: 11893789
    [No Abstract]   [Full Text] [Related]  

  • 40. Perspectives. E-prescribing, formularies play big roles in Rx bill. 2.
    Med Health; 2003 Dec; 57(45):1, 7-8. PubMed ID: 14723167
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.